# Isaac Ro

> Isaac Ro is a Series A investor at Catalio Capital Management backing Biopharma and Health Care. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Catalio Capital Management](https://shizune.co/investors/profile/catalio-capital-management)
- Location: New York, United States
- Total investments: 3
- Last investment: Jun 2025
- Lead investor: 67%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/isaacro/
- X (Twitter): https://twitter.com/isaacro
- Website: http://www.cataliocapital.com
- Facebook: https://www.facebook.com/iro2000

Isaac Ro is a Series A investor at Catalio Capital Management in New York focused on Biopharma and Health Care. Isaac Ro is based out of New York, New York, and is a Partner at Catalio Capital Management and also Board of Directors of Seer. Isaac previously worked at Pillar Biosciences as a Board Observer. Isaac Ro attended the Middlebury College.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biopharma | 2 | 67% |
| Health Care | 2 | 67% |
| Biotechnology | 2 | 67% |
| Medical | 1 | 33% |
| Medical Device | 1 | 33% |

6 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 33% |
| Series D | 1 | 33% |
| Venture - Series Unknown | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Visby Medical | Visby Medical is a diagnostics company that develops PCR-based diagnostic tests for the detection of infectious diseases. The company develops a device platform that aims to redefine the way an illness is tested and treated. They believe that by taking a human-centric, technology-first approach to device development and they can create tools thatare both highly accurate and delightful to use. | $55M | Venture - Series Unknown | Jun 17, 2025 |  |
| PrognomiQ | PrognomiQ is a biotechnology firm that develops test products for the early detection and treatment of cancer and other complex diseases through the power of multi-omics data. | $34.3M | Series D | Nov 05, 2024 |  |
| PinkDx | PinkDx is a biotechnology company. | $40M | Series A | Apr 25, 2024 |  |

3 of 3 investments shown.

## Co-investors
- [aMoon Fund](https://shizune.co/investors/profile/amoon) — VC Fund, 1 deal together
- [Blue Water Life Science Advisors](https://shizune.co/investors/profile/blue-water-life-science-advisors) — VC Fund, 1 deal together
- [Bruker](https://shizune.co/investors/profile/bruker) — VC Fund, 1 deal together
- [Byers Capital](https://shizune.co/investors/profile/byers-capital) — VC Fund, 1 deal together
- [Cedars Sinai](https://shizune.co/investors/profile/cedars-sinai-medical-centerr) — VC Fund, 1 deal together
- [Invus](https://shizune.co/investors/profile/invus) — VC Fund, 1 deal together

## About Catalio Capital Management

VC Fund · Baltimore, United States

Catalio Capital Management is a venture capital firm that invests in breakthrough biomedical technology companies.

5 contacts available at Catalio Capital Management.

| Name | Title | Profile |
| --- | --- | --- |
| Ben Snedeker | Partner and Co-Head Public Equities | https://shizune.co/investors/profile/ben-snedeker |
| George Petrocheilos | Co-Founder & Managing Partner | https://shizune.co/investors/profile/george-petrocheilos |
| Isaac Ro | Partner | https://shizune.co/investors/profile/isaac-ro |
| Jacob Vogelstein | Co-Founder and Managing Partner | https://shizune.co/investors/profile/jacob-vogelstein |
| Kenan Turnacioglu | General Partner | https://shizune.co/investors/profile/kenan-turnacioglu |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Isaac Ro invest in?

Isaac Ro invests primarily in Biopharma, Health Care and Biotechnology startups, most often at Series A and Series D stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Isaac Ro last invest?

The most recent investment recorded for Isaac Ro closed in Jun 2025. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co